[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-urticaria\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-urticaria":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100645406","real-world-evaluation-of-the-effectiveness-of-immunoglobulin-histamine-complex-ihc-histoglob-in-chronic-urticaria-100645406",false,"NCT07680413","Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria","Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex; IHC (Histoglob) in the Management of Chronic Urticaria: A Prospective, Multicenter, Observational Study.","RUSH","Inclusion Criteria:\n\n1. Male or female patients aged ≥13 years.\n2. Able and willing to provide written informed consent (or assent where applicable).\n3. Diagnosed with chronic urticaria with UAS7 prior to enrollment already on first line of treatment for Chronic Urticaria\n4. Prescribed Histoglob injections for the first time at the discretion of treating physician as part of routine car\n\nExclusion Criteria:\n\n1. Known allergy or hypersensitivity to Histoglob or human immunoglobulin product.\n2. Patients with acute allergic attack\n3. Pregnant or lactating women.\n4. History of malignancy or any condition requiring immunosuppressive therapy other than study indication.\n5. Participation in any other clinical study.\n6. Any other condition or circumstance that, in the opinion of the study physician, makes the patient unsuitable for study participation","ALL","13 Years",{"count":20,"type":21},600,"ESTIMATED","OBSERVATIONAL","This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin\u002FHistamine Complex (IHC) in patients with Chronic Urticaria in India.",[25],"Chronic Urticaria",[27,28,29,30,31,32],"Histoglob","urticaria","histaglobulin","Chronic urticaria","RWE study","antihistaminics","RECRUITING","2026-06-25",{"date":36,"type":37},"2026-07-02","ACTUAL",{"date":39,"type":37},"2025-12-31",{"date":41,"type":21},"2026-11",{"name":43,"class":44},"Bharat Serums and Vaccines Limited","INDUSTRY",40,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":76},"100578860","phase-2-treatment-options-for-chronic-urticaria-100578860","NCT06816784","Treatment Options for Chronic Urticaria","COMPARISON OF OUTCOME OF AUTOLOGOUS SERUM THERAPY VS LEVOCETRIZINE IN THE TREATMENT OF CHRONIC URTICARIA","Inclusion Criteria:\n\n* Age: 13-60 years\n* Gender: Both male and female\n* Patients having urticaria for more than 6 weeks diagnosed clinically\n\nExclusion Criteria:\n\n* Pregnancy and lactating females\n* Patients who are immunosuppressed either due to medication or disease.\n* Patients suffering from chronic diseases i-e chronic liver disease, chronic kidney disease.\n* Patients taking steroids in last 2 weeks.","60 Years",{"count":55,"type":21},72,"INTERVENTIONAL",[58],"PHASE2","chronic urticaria is one of the most common dermatological disease affecting many people, exploring most treatment options for its treatment is need of an hour.\n\nOur study aim to compare the efficacy of Autologous Serum Therapy (AST) with levocetirizine in Chronic Urticaria patients",[25],[62,63,64],"chronic urticaria","autologous serum therapy","levocetrizine","NOT_YET_RECRUITING","2025-02-07",{"date":68,"type":37},"2025-02-10",{"date":70,"type":21},"2025-02",{"date":72,"type":21},"2025-07",{"name":74,"class":75},"Sheikh Zayed Medical College","OTHER_GOV",1]